Association Between Gut Microbiota and <i>Helicobacter pylori</i>-Related Gastric Lesions in a High-Risk Population of Gastric CancerOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined the association between gut microbiota composition and Helicobacter pylori-related gastric lesions in a population at high risk for gastric cancer. Researchers used deep sequencing of the microbial 16S ribosomal RNA gene in fecal samples to characterize gut bacterial communities. The work was motivated by concern that H. pylori eradication, while effective for gastric cancer prevention, may carry adverse consequences such as microbial dysbiosis.
Who was studied?
The study included 47 subjects from a high-risk population for gastric cancer. Participants were grouped by H. pylori infection status (negative, past infection, or current infection) and by gastric lesion category, including normal, gastritis, and metaplasia. Fecal samples from these subjects were used for the microbiota analysis.
What were the most important findings?
Bacteroidetes, Firmicutes, and Proteobacteria dominated the fecal microbiota, with average relative abundances of 54.77%, 31.37%, and 12.91% respectively. Microbial diversity, measured by observed species and the Shannon index, was higher in subjects with past or current H. pylori infection than in H. pylori-negative subjects. Bacteroidetes abundance significantly decreased from H. pylori-negative subjects (66.16%) to those with past infection (33.01%), and also declined progressively from normal (76.49%) to gastritis (56.04%) to metaplasia (46.83%). Firmicutes and Proteobacteria showed elevated trends in the past infection group compared with the negative group, though these differences did not reach statistical significance.
What are the greatest implications of this study?
The findings suggest that H. pylori infection history and the severity of associated gastric lesions are linked to measurable shifts in gut bacterial diversity and composition, particularly reductions in Bacteroidetes. This raises the possibility that gut microbial dysbiosis accompanies both H. pylori infection and its downstream gastric pathology, which is relevant to concerns about consequences of eradication therapy. The results support further investigation into how gut microbiota patterns might serve as markers or contributors to gastric lesion progression in high-risk populations.